The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: Is a revision needed?

Abstract

Over a decade ago, we proposed a “unitary” model for the pathogenesis of osteoporosis that identified estrogen deficiency as the predominant cause of both the early, accelerated, and late slow phases of bone loss in postmenopausal women and as a contributing cause of the continuous phase of bone loss in aging men. While this was a plausible model then, new data over the intervening years suggest a need to modify these concepts. Indeed, based largely on rodent studies, a “revisionist” view of the pathogenesis of osteoporosis has been proposed recently that attempts a paradigm shift from the estrogen-centric model to one in which bone loss is largely independent of estrogen deficiency and is driven instead by cell-autonomous age-related factors. However, detailed clinical investigative studies using quantitative computed tomography demonstrate that the onset of cortical bone loss in humans is closely tied to estrogen deficiency; thus the estrogen-centric view is likely correct for cortical bone, which comprises over 80% of the skeleton and is the major structural determinant of fracture risk at most skeletal sites. By contrast, these same studies also demonstrate that trabecular bone loss begins in sex hormone–replete young adults of both sexes. This suggests that a significant proportion of trabecular bone loss is either estrogen-independent or, as suggested by some studies, requires higher levels for its regulation. In this perspective, we critically review these and other findings, leading us to conclude that our original model requires modification but not revision. © 2011 American Society for Bone and Mineral Research.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 91

1. 1.

   Riggs BL, Melton LJ. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med. 1983;75:899-901.

   Not in our library10.1016/0002-9343(83)90860-4

2. 2.

   Riggs BL, Khosla S, Melton LJ. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res. 1998;13:763-773.

   Not in our library10.1359/jbmr.1998.13.5.763

3. 3.

   Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010;31:266-300.

   Not in our library10.1210/er.2009-0024

4. 4.

   Riggs BL, Melton LJ, Robb RA, et al. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res. 2004;19:1945-1954.

   Not in our library10.1359/jbmr.040916

5. 5.

   Riggs BL, Melton LJI, Robb RA, et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res. 2008;23:205-214.

   Not in our library10.1359/jbmr.071020

6. 6.

   Bonnick SL, Bonnick SL. Skeletal anatomy in densitometry. Bone Densitometry in Clinical Practice. 1998;35-78.

   Not in our library

7. 7.

   Rockoff SD, Sweet E, Bleustein J. The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae. Calcif Tissue Res. 1969;3:163-175.

   Not in our library10.1007/bf02058659

8. 8.

   Boutroy S, Van Rietbergen B, Sornay-Rendu E, Munoz F, Bouxsein ML, Delmas P. Finite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal women. J Bone Miner Res. 2008;23:392-399.

   Not in our library10.1359/jbmr.071108

9. 9.

   Cooper C, Melton LJ. Epidemiology of osteoporosis. Trends Endocrinol Metab. 1992;3:224-229.

   Not in our library10.1016/1043-2760(92)90032-v

10. 10.

    van Staa TP, Dennison EM, Leufkens HG, Cooper C. Epidemiology of fractures in England and Wales. Bone. 2001;29:517-522.

    Not in our library10.1016/s8756-3282(01)00614-7

11. 11.

    Riggs BL, Melton LJ. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res. 2002;17:11-14.

    Not in our library10.1359/jbmr.2002.17.1.11

12. 12.

    Richelson LS, Wahner HW, Melton LJI, Riggs BL. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med. 1984;311:1273-1275.

    Not in our library10.1056/nejm198411153112002

13. 13.

    Syed FA, Modder UI, Roforth M, et al. Effects of chronic estrogen treatment on modulating age-related bone loss in female mice. J Bone Miner Res. 2010;25:2438-2446.

    Not in our library10.1002/jbmr.129

14. 14.

    Nelson JF, Felicio LS, Randall PK, Simms C, Finch CE. A longitudinal study of estrous cyclicity in C57BL/6J mice: I. cycle frequency, length and vaginal cytology. Biol Reprod. 1982;27:327-339.

    Not in our library10.1095/biolreprod27.2.327

15. 15.

    Felicio LS, Nelson JF, Finch CE. Longitudinal studies of estrous cyclicity in aging C57BL/6J mice: II. cessation of cyclicity and the duration of persistent vaginal cornification. Biol Reprod. 1984;31:446-453.

    Not in our library10.1095/biolreprod31.3.446

16. 16.

    Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23:279-302.

    Not in our library10.1210/edrv.23.3.0465

17. 17.

    Nelson JF, Felicio LS, Osterburg HH, Finch CE. Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice. Biol Reprod. 1981;24:784-794.

    Not in our library10.1095/biolreprod24.4.784

18. 18.

    Glatt V, Canalis E, Stadmeyer L, Bouxsein ML. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res. 2007;22:1197-1207.

    Not in our library10.1359/jbmr.070507

19. 19.

    Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston C. Sex steroids and bone mass in older men: positive associations with serum estrogens and negative associations with androgens. J Clin Invest. 1997;100:1755-1759.

    Not in our library10.1172/jci119701

20. 20.

    Khosla S, Melton LJ, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab. 1998;83:2266-2274.

    Not in our library10.1210/jcem.83.7.4924

21. 21.

    Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study. J Bone Miner Res. 1997;12:1833-1843.

    Not in our library10.1359/jbmr.1997.12.11.1833

22. 22.

    Center JR, Nguyen TV, Sambrook PN, Eisman JA. Hormonal and biochemica parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab. 1999;84:3626-3635.

    Not in our library10.1210/jcem.84.10.6051

23. 23.

    Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Piaseau N, Chailurkit L. Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol. 1998;49:803-809.

    Not in our library10.1046/j.1365-2265.1998.00631.x

24. 24.

    van den Beld AW, de Jong FH, Grobbee DE, Pols HAP, Lamberts SWJ. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab. 2000;85:3276-3282.

    Not in our library10.1210/jcem.85.9.6825

25. 25.

    Amin S, Zhang Y, Sawin CT, et al. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med. 2000;133:951-963.

    Not in our library10.7326/0003-4819-133-12-200012190-00010

26. 26.

    Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab. 2001;86:192-199.

    Not in our library10.1210/jcem.86.1.7126

27. 27.

    Khosla S, Melton LJ, Atkinson EJ, O'Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab. 2001;86:3555-3561.

    Not in our library10.1210/jcem.86.8.7736

28. 28.

    Gennari L, Merlotti D, Martini G, et al. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J Clin Endocrinol Metab. 2003;88:5327-5333.

    Not in our library10.1210/jc.2003-030736

29. 29.

    Van Pottelbergh I, Goemaere S, Kaufman JM. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. J Clin Endocrinol Metab. 2003;88:3075-3081.

    Not in our library10.1210/jc.2002-021691

30. 30.

    Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest. 2000;106:1553-1560.

    Not in our library10.1172/jci10942

31. 31.

    Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab. 2003;88:204-210.

    Not in our library10.1210/jc.2002-021036

32. 32.

    Doran PM, Riggs BL, Atkinson EJ, Khosla S. Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men. J Bone Miner Res. 2001;16:2118-2125.

    Not in our library10.1359/jbmr.2001.16.11.2118

33. 33.

    Uebelhart B, Herrmann F, Pavo I, Draper MW, Rizzoli R. Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels. J Bone Miner Res. 2004;19:1518-1524.

    Not in our library10.1359/jbmr.040503

34. 34.

    Amin S, Zhang Y, Felson DT, et al. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med. 2006;119:426-433.

    Not in our library10.1016/j.amjmed.2005.10.048

35. 35.

    Mellstrom D, Vandenput L, Mallmim H, et al. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res. 2008;23:1552-1560.

    Not in our library10.1359/jbmr.080518

36. 36.

    Khosla S, Melton LJ, Robb RA, et al. Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men. J Bone Miner Res. 2005;20:730-740.

    Not in our library10.1359/jbmr.041228

37. 37.

    Khosla S, Amin S, Orwoll E. Osteoporosis in men. Endocr Rev. 2008;29:441-464.

    Not in our library10.1210/er.2008-0002

38. 38.

    Lufkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 1992;117:1-9.

    Not in our library10.7326/0003-4819-117-1-1

39. 39.

    Bonewald LF. Osteocyte messages from a bony tomb. Cell Metab. 2007;5:410-411.

    Not in our library10.1016/j.cmet.2007.05.008

40. 40.

    Almeida M, Martin-Millan M, Plotkin LI, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007;282:27285-27297.

    Not in our library10.1074/jbc.m702810200

41. 41.

    Tomkinson A, Reeve J, Shaw RW, Noble BS. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab. 1997;82:3128-3135.

    Not in our library10.1210/jcem.82.9.4200

42. 42.

    Mirza FS, Padhi ID, Raisz LG, Lorenzo JA. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab. 2010;95:1991-1997.

    Not in our library10.1210/jc.2009-2283

43. 43.
    Regulation of circulating sclerostin levels by sex steroids in women and in men · 2010

    No notice
44. 44.

    Armstrong VJ, Muzylak M, Sunters A, et al. WNT/B-Catenin signaling is a component of osteoblastic bone cells' early responses to load-bearing, and requires estrogen receptor a. J Biol Chem. 2007;282:20715-20727.

    Not in our library10.1074/jbc.m703224200

45. 45.

    Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology. 1999;140:4367-4370.

    Not in our library10.1210/endo.140.9.7131

46. 46.

    Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest. 2003;111:1221-1230.

    Not in our library10.1172/jci17215

47. 47.

    Roggia C, Gao Y, Cenci S, et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A. 2001;98:13960-13965.

    Not in our library10.1073/pnas.251534698

48. 48.

    Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002;23:90-119.

    Not in our library10.1210/edrv.23.1.0456

49. 49.

    Weitzmann MN, Pacifici R. The role of T lymphocytes in bone metabolism. Immunol Rev. 2005;208:154-168.

    Not in our library10.1111/j.0105-2896.2005.00324.x

50. 50.

    Srivastava S, Weitzmann MN, Cenci S, Ross FP, Adler S, Pacifici R. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest. 1999;104:503-513.

    Not in our library10.1172/jci7094

51. 51.
    Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression · 2000

    Not checked
52. 52.

    Nakamura T, Imai Y, Matsumoto T, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of fas ligand in osteoclasts. Cell. 2007;130:811-823.

    Not in our library10.1016/j.cell.2007.07.025

53. 53.

    Martin-Millan M, Almeida M, Ambrogini E, et al. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol. 2010;24:323-334.

    Not in our library10.1210/me.2009-0354

54. 54.

    Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL. Effect of blockade of TNF-a and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res. 2007;22:724-729.

    Not in our library10.1359/jbmr.070207

55. 55.

    Garnero P, Sornay-Rendu E, Chapuy M, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996;11:337-349.

    Not in our library10.1002/jbmr.5650110307

56. 56.

    Gregorio GB, Yamamoto M, Ali AA, et al. Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17beta-estradiol. J Clin Invest. 2001;107:803-812.

    Not in our library10.1172/jci11653

57. 57.

    Okazaki R, Inoue D, Shibata M, et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology. 2002;143:2349-2356.

    Not in our library10.1210/endo.143.6.8854

58. 58.

    Dang ZC, Van Bezooijen RL, Karperien M, Papapoulos SE, Lowik CWGM. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res. 2002;17:394-405.

    Not in our library10.1359/jbmr.2002.17.3.394

59. 59.

    Bord S, Horner A, Beavan S, Compston J. Estrogen receptors alpha and beta are differentially expressed in developing human bone. J Clin Endocrinol Metab. 2001;86:2309-2314.

    Not in our library10.1210/jcem.86.5.7513

60. 60.

    Sims NA, Dupont S, Krust A, et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors beta in bone remodeling in females but not in males. Bone. 2002;30:18-25.

    Not in our library10.1016/s8756-3282(01)00643-3

61. 61.

    Hall JM, McDonnell DP. The estrogen receptor beta-isoform (ER beta) of the human estrogen receptor modulates ER alpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999;140:5566-5578.

    Not in our library10.1210/endo.140.12.7179

62. 62.

    Windahl SH, Hollberg K, Vidal O, Gustafsson JA, Ohlsson C, Andersson G. Female estrogen receptor B-/- mice are partially protected against age-related trabecular bone loss. J Bone Miner Res. 2001;16:1388-1398.

    Not in our library10.1359/jbmr.2001.16.8.1388

63. 63.

    Genant HK, Cann CE, Ettinger B, Gordan GS. Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med. 1982;97:699-705.

    Not in our library10.7326/0003-4819-97-5-699

64. 64.

    Ritchie LD, Fung EB, Halloran BP, et al. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am J Clin Nutr. 1998;67:693-701.

    Not in our library10.1093/ajcn/67.4.693

65. 65.

    Sowers MF, Corton G, Shapiro B, et al. Changes in bone density with lactation. JAMA. 1993;269:3130-3135.

    Not in our library

66. 66.

    Naylor KE, Iqbal P, Fledelius C, Fraser RB, Eastell R. The effect of pregnancy on bone density and bone turnover. J Bone Miner Res. 2000;15:129-137.

    Not in our library10.1359/jbmr.2000.15.1.129

67. 67.

    Budy AM. Osteogenetic properties of estrogenic hormones. Ann NY Acad Sci. 1956;64:428-431.

    Not in our library

68. 68.

    Khosla S, Westendorf JJ, Oursler MJ. Building bone to reverse osteoporosis and repair fractures. J Clin Invest. 2008;118:421-428.

    Not in our library10.1172/jci33612

69. 69.

    Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009;460:587-591.

    Not in our library10.1038/nature08197

70. 70.

    Edwards JR, Zainabadi K, Elefteriou E, et al. The aging associated gene SIRT-1 regulates osteoclast formation and bone mass in vivo. J Bone Miner Res. 2007;22(Suppl):S29.

    Not in our library

71. 71.

    Edwards JR, Zainabadi K, Lwin ST, et al. The longevity genen SIRT-1 independently controls both osteoblast and osteoclast function. J Bone Miner Res. 2008;23(Suppl):S28.

    Not in our library

72. 72.

    Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-342.

    Not in our library10.1038/nature05354

73. 73.

    Su JL, Yang CY, Zhao M, Kuo ML, Yen ML. Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. J Biol Chem. 2007;282:19385-19398.

    Not in our library10.1074/jbc.m702452200

74. 74.

    Grassi F, Tell G, Robbie-Ryan M, et al. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci USA. 2007;104:15087-15092.

    Not in our library10.1073/pnas.0703610104

75. 75.

    Cummings SR, Browner WS, Bauer D, et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med. 1998;339:733-738.

    Not in our library10.1056/nejm199809103391104

76. 76.

    McKane RW, Khosla S, Risteli J, Robins SP, Muhs JM, Riggs BL. Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women. Proc Assoc Am Physicians. 1997;109:174-180.

    Not in our library

77. 77.

    Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729-740.

    Not in our library10.1038/nrm2233

78. 78.

    Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab. 1995;80:3304-3310.

    Not in our library10.1210/jcem.80.11.7593443

79. 79.

    Gennari C, Agnusdei D, Nardi P, Civitelli R. Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women. J Clin Endocrinol Metab. 1990;71:1288-1293.

    Not in our library10.1210/jcem-71-5-1288

80. 80.

    McKane WR, Khosla S, Burritt MF, et al. Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause - a clinical research center study. J Clin Endocrinol Metab. 1995;80:3458-3464.

    Not in our library10.1210/jcem.80.12.8530583

81. 81.

    Heshmati HM, Khosla S, Robins SP, O'Fallon WM, Melton LJ, Riggs BL. Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res. 2002;17:172-178.

    Not in our library10.1359/jbmr.2002.17.1.172

82. 82.

    Khosla SK, Atkinson EJ, Melton LJ, Riggs BL. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab. 1997;82:1522-1527.

    Not in our library10.1210/jcem.82.5.3946

83. 83.

    Wehr E, Pilz S, Boehm BO, Marz W, Obermayer-Pietsch B. Association of vitamin D status with serum androgen levels in men. Clin Endocrinol. 2010;73:243-248.

    Not in our library10.1111/j.1365-2265.2009.03777.x

84. 84.

    Prior JC. Progesterone as a bone-trophic hormone. Endocr Rev. 1990;11:386-398.

    Not in our library10.1210/edrv-11-2-386

85. 85.

    Wierman ME, Basson R, Davis SR, et al. Androgen therapy in women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2006;91:3697-3710.

    Not in our library10.1210/jc.2006-1121

86. 86.

    Perrien DS, Achenbach SJ, Bledsoe SE, et al. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. J Clin Endocrinol Metab. 2006;91:1848-1854.

    Not in our library10.1210/jc.2005-2423

87. 87.

    Ebeling PR, Atley LM, Guthrie JR, et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab. 1996;81:3366-3371.

    Not in our library10.1210/jcem.81.9.8784098

88. 88.

    Sowers MFR, Jannausch M, McConnell D, et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinal Metab. 2006;91:1261-1267.

    Not in our library10.1210/jc.2005-1836

89. 89.

    Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell. 2006;125:247-260.

    Not in our library10.1016/j.cell.2006.01.051

90. 90.

    Gao J, Tiwari-Pandey R, Samadfam R, et al. Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone (FSH). Endocrinology. 2007;148:2613-2621.

    Not in our library10.1210/en.2006-1404

91. 91.

    Drake MT, McCready L, Hoey KA, Atkinson EJ, Khosla S. Effects of suppression of follicle stimulating hormone secretion on bone resorption markers in postmenopausal women. J Clin Endocrinol Metab. 2010;95:5063-5068.

    Not in our library10.1210/jc.2010-1103

Cited by papers we hold 1

• Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.